Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies

被引：5
|
作者：
Rosell, R.
Molina, M. A.
Costa, C.
Taron, M.
Bertran-Alamillo, J.
Mayo, C.
Benlloch, S.
Moran, T.
Cardenal, F.
Porta, R.
机构：
[1] Catalan Inst Oncol, Badalona, Spain
[2] USP Inst Univ Dexeus, Pangaea Biotech, Barcelona, Spain
[3] USP Dexeus Univ Inst, Pangaea Biotech, Barcelona, Spain
[4] USP Inst Dexeus, Pangaea Biotech, Barcelona, Spain
[5] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona, Spain
[6] Bellvitge Hosp, Catalan Inst Oncol, Barcelona, Spain
[7] Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7514
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Non-Small Cell Lung Cancer with De Novo EGFR T790M Mutation: Clinical Features of 22 Cases
    Heo, Mi Hwa
    Kim, Hee Kyung
    Lee, Hansang
    Cho, Jinhyun
    Park, Juyoun
    Jeong, Su-Mi
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1237 - S1238
  • [42] Phase I/II Study of AC0010, Mutant Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
    Wu, Yi Long
    Zhou, Qing
    Liu, Xiaoqing
    Zhang, Li
    Zhou, Jianying
    Wu, Lin
    An, Tongtong
    Cheng, Ying
    Zheng, Xin
    Hu, Bei
    Jiang, Ji
    Fang, Xin
    Xu, Wanhong
    Xu, Xiao
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S437 - S438
  • [43] The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
    Pan, Guoqiang
    Chen, Kaiyan
    Yu, Xiaoqing
    Sheng, Jiamin
    Fan, Yun
    [J]. TRANSLATIONAL CANCER RESEARCH, 2021, 10 (06) : 2895 - 2905
  • [44] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Shuhang Wang
    Shundong Cang
    Delong Liu
    [J]. Journal of Hematology & Oncology, 9
  • [45] Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
    Wang, Shuhang
    Cang, Shundong
    Liu, Delong
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [46] Exhaled breath condensate confirming T790M mutation in EGFR-mutated Non-Small Cell Lung Cancer
    Goggin, Caitriona
    Nay, Myo Oo
    Ryan, Daniel
    Toomey, Sinead
    Hennessy, Bryan
    Calvert, Paula
    [J]. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 4
  • [47] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    [J]. CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [48] Association between low-frequency pretreatment EGFR T790M mutation and tumor immune microenvironment in patients with EGFR-mutated non-small cell lung cancer
    Matsumoto, Yoshiya
    Sawa, Kenji
    Fukui, Mitsuru
    Oyanagi, Jun
    Izumi, Motohiro
    Ogawa, Koichi
    Suzumura, Tomohiro
    Watanabe, Tetsuya
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Asai, Kazuhisa
    Kimura, Tatsuo
    Yamamoto, Nobuyuki
    Kawaguchi, Tomoya
    Koh, Yasuhiro
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [49] The Usefulness of "Serum" Samples to Detect EGFR T790M Mutation in EGFR-TKI-Resistant Non-Small Cell Lung Cancer
    Kobayashi, K.
    Naoki, K.
    Ikemura, S.
    Yasuda, H.
    Kawada, I.
    Soejima, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S936 - S937
  • [50] Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
    Zhang, Hui
    Hu, Yi
    Wang, Yan
    Song, Xia
    Hu, Ying
    Ma, Li
    Yang, Xinjie
    Li, Kun
    Qin, Na
    Wang, Jinghui
    Lv, Jialin
    Li, Xi
    Zhang, Xinyong
    Zhang, Quan
    Wu, Yuhua
    Yao, Guangyin
    Zhang, Shucai
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
12345